A Pilot Study To Evaluate Angiogenesis After Treatment With Bevacizumab (Anti-VEGF Humanized Monoclonal Antibody) In Previously Untreated Patients With Inflammatory Breast Cancer or Locally Advanced Breast Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bevacizumab; Docetaxel; Doxorubicin
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 Jul 2017 Biomarkers information updated
- 09 Apr 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 09 Apr 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.